Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome

Journal of Rheumatology

Volumn 35, Issue 1, 2008, Pages 169-171

  Legault, Dominic ^a   McDermott, John ^b   Crous Tsanaclis, Ana Maria ^a   Boire, Gilles ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b Lakeshore General Hospital   (Canada)

Author keywords

Autoantibodies; Biopsy; Major histocompatibility complex; Myositis; Neoplasms

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR ANTIGEN; JO 1 ANTIBODY;

ADULT; AGED; ANTISYNTHETASE SYNDROME; ARTICLE; CANCER PATIENT; CASE REPORT; CLINICAL FEATURE; FEMALE; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MYOSITIS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BIOPSY, NEEDLE; FEMALE; HISTIDINE-TRNA LIGASE; HUMANS; LIGASES; MALE; MIDDLE AGED; MUSCLES; NEOPLASMS; POLYMYOSITIS; SYNDROME;

EID: 38149037875     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
2. Hengstman GJ, van Engelen BG, van Venrooij WJ. Myositis specific autoantibodies: changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol 2004;16:692-9.
3. Dalakas MC, Hohlfeld R. Polymositis and dermatomyositis. Lancet 2003;362:971-82.
4. Hoogendijk JE, Amato AA, Lecky BR, et al. 119th ENMC International Workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands (workshop report). Neuromuscular Dis 2004;14:337-45.
5. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine 2005;84:231-49.
6. Hengstman GJD, van Engelen BGM, van Venrooij WJ. Myositis-specific autoantibodies: changing insights in pathophysiology and clinical associations. Curr Opin Rheumatol 2004;16:692-9.
7. Yazici Y, Kagen LJ. The association of malignancy with myositis. Curr Opin Rheumatol 2000;12:498-500.
8. Ponyi A, Constantin T, Garami M, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann NY Acad Sci 2005;1051:64-71.
9. Iwasaki Y, Mohri T, Muraki M. A case of interstitial pneumonitis associated with polymyositis complicated by renal cell carcinoma. Nihon Kyobu Shikkan Gakkai Zasshi 1992;30:1858-63.
10. Watkins J, Farzaneh-Far R, Tahir H, Wykes F, Studdy PR, Beynon HLC. Jo-1 syndrome with associated poorly differentiated adenocarcinoma. Rheumatology Oxford 2004;43:389-90.
11. van der Bijl AE, Meinders AE, van Duinen SG, Tamsma JT. A nasal squamous cell carcinoma complicated by a paraneoplastic syndrome consisting of a myositis and anti-Jo-1 autoantibodies. Eur J Intern Med 2005;16:369-71.
12. Nakanishi S, Hatayama T. Adenocarcinoma of the prostate associated with anti Jo-1 antibody positive polymyositis. Hinyokika Kiyo 2006;52:289-91.
13. Gendron M, Roberge D, Boire G. Heterogeneity of human Ro ribonucleoproteins (RNPs): nuclear retention of Ro RNPs containing the human hY5 RNA in human and mouse cells. Clin Exp Immunol 2001;125:162-8.
14. Shamim EA, Rider LG, Miller FW. Update on the genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 2000;12:482-91.
15. O'Hanlon TP, Carrick DM, Arnett FC, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles and motifs define clinicopathologic groups in Caucasians. Medicine Baltimore 2005;84:338-49.
16. Chinoy H, Salway F, Fertig N, et al, for the UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC). In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res Ther 2006;8:R13.
17. O'Hanlon TP, Carrick DM, Targoff IN, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine Baltimore 2006;85:111-27.
18. van der Meulen MFG, Bronner IM, Hoogendijk JE, et al. Polymyositis: an overdiagnosed entity. Neurology 2003;61:316-21.
19. Askanas V, Engel WK. Unicorns, dragons, polymyositis, and other mythical beasts. Neurology 2004;63:403-4.